Richard Hynes | |
---|---|
Born | Richard Olding Hynes[1] (1944-11-29)29 November 1944 (age 80)[3] |
Citizenship | American British[2] |
Education | University of Cambridge (BA,MA) Massachusetts Institute of Technology (PhD) |
Known for | Cell adhesion research Discovery offibronectin |
Awards | Canada Gairdner International Award E.B. Wilson Medal Robert J. and Claire Pasarow Foundation Medical Research Award Albert Lasker Award for Basic Medical Research |
Scientific career | |
Fields | Cell biology |
Institutions | Massachusetts Institute of Technology Howard Hughes Medical Institute Broad Institute |
Thesis | Regulation of gene expression during early cleavage in sea urchin embryos (1971) |
Doctoral advisor | Paul R. Gross |
Doctoral students | Denisa Wagner |
Richard Olding HynesFRS (born 29 November 1944) is a Britishbiologist, aHoward Hughes Medical Institute Investigator,[4] and theDaniel K. LudwigProfessor forCancer Research at theKoch Institute for Integrative Cancer Research,Massachusetts Institute of Technology (MIT).[5] His research focuses oncell adhesion and the interactions betweencells and theextracellular matrix, with a particular interest in understanding molecular mechanisms ofcancer metastasis.[5] He is well known as a co-discoverer offibronectin molecules, a discovery that has been listed byThomson Scientific ScienceWatch as aNobel Prize candidate.[6]
Hynes earned hisB.A. in 1966 andM.A. in 1970 from theUniversity of Cambridge, both inbiochemistry. He received hisPh.D. inbiology from theMassachusetts Institute of Technology in 1971. He worked as apostdoctoral fellow at theImperial Cancer Research Fund from 1971 to 1974.[4][5][7]
Hynes became a faculty member in thebiology department atMIT in 1973 and was promoted tofull professor in 1983. He was awardedHoward Hughes Medical Institute Investigator status in 1988. He served as the head of the biology department from 1989 to 1991 and as the director of the MIT Center for Cancer Research from 1991 to 2001, and became theDaniel K. Ludwig Professor for Cancer Research and affiliated with theKoch Institute for Integrative Cancer Research in 1999. Since 2004 he has been an associate member of theBroad Institute.[7][8]
Hynes served as the president of theAmerican Society for Cell Biology in 2000.[7] He has been a member of the Board of Governors of theWellcome Trust since 2007.[9] He also served on the Life Sciences jury for theInfosys Prize in 2012.
He has also published onpublic policy and participated in the development of United States research guidelines forstem cell research, particularlyembryonic stem cells.[10]